Table 4.
Distribution of ACE and ACTN3 variants in the study groups.
| ACE | CMW (n = 20) | EMW (n = 20) | C-EMW (n = 20) | IMW (n = 20) | p Value |
|---|---|---|---|---|---|
| II | 1 (5.0%) | 3 (15.0%) | 4 (20.0%) | 2 (10.0%) | |
| ID | 10 (50.0%) | 9 (45.0%) | 10 (50.0%) | 10 (50.0%) | 0.847 |
| DD | 9 (45.0%) | 8 (40.0%) | 6 (30.0%) | 8 (40.0%) | |
| ACTN3 | CMW (n = 20) | EMW (n = 20) | C-EMW (n = 20) | IMW (n = 20) | |
| RR | 13 (65.0%) | 5 (25.0%) | 6 (30.0%) | 9 (45.0%) | |
| RX | 5 (25.0%) | 11 (55.0%) | 11 (55.0%) | 9 (45.0%) | 0.213 |
| XX | 2 (10.0%) | 4 (20.0%) | 3 (15.0%) | 2 (10.0%) |
CMW, concentric muscle work; C-EMW, concentric-eccentric muscle Work; EMW, eccentric muscle work; IMW, isometric muscle work.